Erbium doped glass for optical amplification in detecting a photoplethysmography
A user device for monitoring a physical condition of a user, such as a heart rate or blood oxygen level, includes an erbium doped glass component and a light source. The light source is configured to generate light equal to an excitation frequency of the erbium doped glass. The erbium doped glass component is configured to generate, through photoluminescence, one or more peaks of higher intensity light corresponding to a wavelength which can be used to monitor a physical condition of a user. The amplified light is sent to the user and received back at a photodetector, which can then algorithmically determine a physical condition of a user.
1. A wearable device comprising:
an amplification configured to receive light of a first wavelength and first intensity on a first surface and transmit light of a second wavelength with a second intensity to a user via a second surface;
a photodetector configured to receive light of the second wavelength incident from skin of the user when the wearable device is in contact with the skin of the user; and
a processor configured to determine a physical condition of the user based on at least a signal received from the photodetector,
wherein:
the first wavelength is an excitation frequency of the amplification layer, and
the second intensity is higher than the first intensity.
2. The wearable device of claim 1 , wherein the amplification layer further transmits light of a third wavelength and the photodetector receives light of the third wavelength.
3. The wearable device of claim 2 , wherein the processor is further configured to monitor a blood oxygen level based on light of the second wavelength and the processor is configured to monitor a heart condition based on light of a third wavelength.
4. The wearable device of claim 1 , wherein the photodetector generates electrical signals responsive to the light received.
5. The wearable device of claim 4 , wherein processor is electrically coupled to the photodetector.
6. The wearable device of claim 5 , wherein the processor is further configured to evaluate a health state of a user based on received photons of the second wavelength.
7. The wearable device of claim 1 , further comprising a paint, which blocks a visible light spectrum, on either the first surface or the second surface of the amplification layer.
8. The wearable device of claim 1 , wherein the first wavelength is within an infra-red spectrum.
9. The wearable device of claim 1 , wherein the amplification layer is erbium doped phosphate glass.
10. The wearable device of claim 9 , wherein the amplification layer is erbium doped phosphate glass with between 0.4 mole percent and 0.6 mole percent of erbium.
11. The wearable device of claim 9 , wherein the second wavelength is from a range of 550 to 750 nm wavelength.
12. The wearable device of claim 1 , wherein the second wavelength is different than the first wavelength.
13. A method of monitoring a physical parameter of a user, comprising:
providing an amplification layer, the amplification layer configured to have a first excitation wavelength and generate a second excitation wavelength;
generating by a light source light of a first wavelength, the first wavelength corresponding to the first excitation wavelength;
receiving the light of a first wavelength at the amplification layer;
generating light of a second wavelength at the amplification layer responsive to the received light of a first wavelength;
transmitting the light of a second wavelength from the amplification layer to the user;
receiving from the user and at a photodetector, the light of a second wavelength; and
evaluating, by a processor, the physical parameter of the user based on at least the light of a second wavelength received at the photodetector, wherein the physical parameter is at least one of a heart rate or a blood oxygen level of the user.
14. The method of claim 13 , further comprising generating light of a third wavelength at the amplification layer.
15. The method of claim 14 , wherein the second wavelength corresponds to red light and the third wavelength corresponds to green light.
16. The method of claim 15 , wherein evaluation by a processor comprises execution of a machine learning algorithm to evaluate an underlying health condition of the user.
17. A wearable device, comprising:
a housing, the housing comprising a back portion adapted to be placed adjacent to a user's skin;
an amplification layer with a first side and a second side, the amplification layer configured to receive light of a first wavelength and first intensity and transmit light of a second wavelength with a second intensity;
a photodetector configured to receive light of the second wavelength incident from the user's skin when the back portion of the wearable device is placed adjacent to the user's skin; and
a processor configured to determine a physical condition of a user based on at least a signal received from the photodetector,
wherein:
the first wavelength is an excitation frequency of the amplification layer, and
the second intensity is higher than the first intensity.
18. The wearable device of claim 17 , wherein the amplification layer is doped with erbium.
19. The wearable device of claim 17 , wherein the amplification layer is at least partially painted with an ink to block a visible light spectrum.
20. The wearable device of claim 17 , wherein the second wavelength is different than the first wavelength.